- Filed
- Feb 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 24, 2025 | 43.74M sh |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $1.72B |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $1.25B |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $2.7B |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $4.64B |
| Current Assets | FY 2024 · Dec 31, 2023 | $4.16B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 53.46M sh |
| Capex restated | FY 2024 · Dec 31, 2022 | $104.3M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2022 | $748.3M |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2022 | $1.13B |
| Total Assets restated | FY 2024 · Dec 31, 2022 | $5.4B |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $4.41 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $4.60 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $285.1M |
| Net Income restated | FY 2024 · Dec 31, 2022 | $231M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | $385.4M |
| Revenue restated | FY 2024 · Dec 31, 2022 | $3.36B |